City Insurance PLC. announcements
354 Dhaka Stock Exchange announcements for City Insurance PLC. (CITYGENINS) since 2008: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (16).
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.99 for July-September 2025 as against Tk. 0.64 for July-September 2024; EPS was Tk. 2.62 for January-September 2025 as against Tk. 2.37 for January-September 2024. NOCFPS was Tk. 2.39 for January-September 2025 as against Tk. 1.54 for January-September 2024. NAV per share was Tk. 23.77 as on September 30, 2025 and Tk. 21.15 as on December 31, 2024. Reasons for deviation: (cont.1) (Cont. news of CITYGENINS): NAV has been increased for the period from 01st January 2025 to 30th September 2025 (Un-audited) in comparison to the same period of the previous year 2024 because the company's investments in FDR has been increased. (end) (Cont. news of CITYGENINS): EPS has been increased for the period from 01st January 2025 to 30th September 2025 (Un-audited) in comparison to the same period of the previous year 2024 because of investment and others income have been increased. NOCFPS has been increased for the period from 01st January 2025 to 30th September 2025 (Un-audited) in comparison to the same period of the previous year 2024 because the company's premium collection has been increased. (cont.2)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2025 at 4:00 PM to consider, among others, Un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2025.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.73 for April - June 2025 as against Tk. 0.89 for April - June 2024; EPS was Tk. 1.63 for January - June 2025 as against Tk. 1.74 for January - June 2024; NOCFPS was Tk. 1.98 for January - June 2025 as against Tk. 1.42 for January - June 2024. NAV per share was Tk. 22.47 as on June 30, 2025 and Tk. 21.15 as on December 31, 2024. (cont.) (Cont. News of CITYGENINS): Reasons for deviation: EPS has been decreased in comparison to the same period of the previous year because of claims and re-insurance expenses have been increased. NOCFPS has been increased in comparison to the same period of the previous year because the company's premium collection increased. NAV has been increased in comparison to the same period of the previous year because the company's investment in FDR has been increased. (end)
- Credit Rating Result
Credit Rating Information and Services Limited (CRISL) has assigned the company as 'AAA' rating along with Stable outlook in consideration of its audited financials up to December 31, 2024 also unaudited financials up to March 31, 2025 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 28, 2025 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2025.
- Query Response
In response to the DSE query today i.e., 08.07.2025, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike of shares.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.90 for January-March 2025 as against Tk. 0.85 for January-March 2024; NOCFPS was Tk. 1.16 for January-March 2025 as against Tk. 0.79 for January-March 2024. NAV per share was Tk. 21.75 as on March 31, 2025 and Tk. 21.15 as on December 31, 2024. Reasons for deviation: EPS has been increased in 1st quarter ended on 31 March, 2025 (Un-audited) in comparison to the same period of the previous year because of premium income has been increased sharply. (cont.) (Cont. News of CITYGENINS): NAV has been increased in 1st quarter ended on 31st March, 2025 (Un-audited) in comparison to the same period of the previous year because of the company's investment in FDR has been increased. NOCFPS has been increased in the 1st quarter ended on 31st March, 2025 (Un-audited) in comparison to the same period of the previous year because of the company's premium collection has been increased. (end)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 13, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2025.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2024 to the respective shareholders.
- Update of Information
The company has requested the concerned Brokerage Houses/DPs to provide the statement both hard and soft copy to [email protected] with details of their margin loan holders entitled to Final Dividend 2024 on or before 13 March 2025. The statement should include Shareholder's name, BOID Number, Email, client-wise shareholding position, contact person etc.
- Resumption after Record date
Trading of the shares of the company will resume on 02.03.2025.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e. 27.02.2025.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 25.02.2025 to 26.02.2025 and trading of the shares will remain suspended on record date i.e., 27.02.2025.
- Dividend Declaration
The Board of Directors of the company has recommended 10% cash dividend for the year ended December 31, 2024. The Company has reported EPS of Tk. 3.08, NAV per share of Tk. 21.15 and NOCFPS of Tk. 2.44 for the year ended December 31, 2024 as against Tk. 3.02, Tk. 20.40 and Tk. 2.53 respectively for the year ended December 31, 2023. Date of AGM: 24.03.2025, Time: 3:00 PM. Record Date: 27.02.2025. Mode of AGM: Hybrid System i.e., at BCIC Auditorium 30-31 Dilkusha C/A, Dhaka with (cont.1) (Continuation news of CITYGENINS): NOCFPS has been decreased in the current year ended 31st December, 2024 with comparison to the previous year because the company's liabilities payments have been increased. NAV per share has been increased in the current year ended 31st December, 2024 with comparison to the previous year because the company's cash & cash equivalents have been increased sharply. (end) (Continuation news of CITYGENINS): physical presence and also Digital platform virtually. Reasons for significant deviation in EPS, NOCFPS and NAVPS: EPS has been increased in the current year ended on 31st December, 2024 with comparison to the previous year because the company's others income has been increased significantly. (cont.2)
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (09.02.2025) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 06, 2025 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.